Meanwhile, SEZ6L2 may upregulate the expression of PDGF, VEGF, and VEGF receptors through positive feedback regulation, thus ultimately promoting the angiogenesis of cholangiocarcinoma [32]. Here, SEZ6L2 is linked to cholangiocarcinoma.